Qiagen N.V. Profile Avatar - Palmy Investing

Qiagen N.V.

QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample mater…
Medical - Diagnostics & Research
NL, Venlo [HQ]

Ratios

15 Sheets · Starting from 2023
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
66.06 65.80 64.10 65.69 62.63 64.32 64.51 63.13 65.08 66.65 65.86 65.65 64.43 64.65 62.23
Profit Margin
13.64 13.27 8.21 10.32 5.31 8.67 9.92 6.01 2.85 12.68 -2.72 3.94 22.77 19.76 17.37
Operating Margin
17.85 17.34 8.51 13.54 4.86 11.96 13.72 7.39 10.82 17.75 22.03 29.67 27.98 24.82 22.66
EPS Growth
48.94 -8.57 -32.81 32.56 -45.61 67.74 9.62 -36.84 -50.00 366.67 -122.62 273.68 603.03 -17.24 -19.79
Return on Assets (ROA)
3.63 3.69 2.56 3.14 1.69 2.62 3.03 1.87 0.80 3.31 -0.79 1.23 8.34 6.73 5.58
Return on Equity (ROE)
6.01 5.83 3.77 4.77 2.54 4.40 4.97 3.08 1.59 7.23 -1.63 2.97 16.55 12.21 8.96
Return on Invested Capital (ROIC)
4.44 4.69 3.13 4.25 3.29 4.16 4.65 3.79 1.26 4.67 4.22 5.85 10.24 8.24 6.62
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
25.05 22.31 15.71 20.53 20.68 26.31 25.31 24.79 34.92 37.82 32.59 33.94 31.59 29.60 25.05
Debt/Equity
41.51 35.25 23.15 31.20 31.15 44.23 41.43 40.97 69.25 82.51 67.27 81.62 62.71 53.70 40.24
Debt/EBITDA
41.24 20.60 278.43 221.25 496.73 399.88 212.96 203.22 289.23 203.24 190.73 186.93 114.98 137.21 144.95
Debt/Capitalization
29.33 26.06 18.80 23.78 23.75 30.67 29.29 29.06 40.92 45.21 40.22 44.94 38.54 34.94 28.69
Interest Debt per Share USD
4.92 4.01 2.73 3.85 3.89 5.42 4.89 4.90 7.93 9.94 8.09 9.48 9.03 8.70 7.16
Debt Growth
-2.73 -8.20 -32.42 43.57 -0.18 38.63 -9.60 0.71 64.77 23.66 -21.52 18.78 -4.19 -4.14 -13.45
Liquidity
Current Ratio
355.09 351.33 155.39 331.21 273.23 266.14 358.34 336.40 507.39 221.67 165.06 267.46 139.02 245.65 198.98
Quick Ratio
285.52 294.23 109.10 257.79 203.78 201.85 268.91 270.47 426.60 183.12 124.08 188.02 94.07 178.76 145.78
Cash Ratio
219.84 213.28 45.91 131.18 98.00 90.97 108.07 142.39 202.50 119.22 65.55 97.26 58.03 74.98 61.90
Operating Cash Flow Ratio
- - - - - - - - - - - - 100 100 - - - - - - - - - - - - - -
Turnover
Inventory Turnover
261.94 293.66 317.57 318.15 379.79 362.76 332.84 361.28 317.44 307.46 305.30 220.67 244.51 211.46 186.35
Receivables Turnover
488.68 521.96 468.31 432.75 424.67 456.56 425.87 442.99 384.52 388.53 357.28 425.22 621.78 661.47 381.14
Payables Turnover
782.99 777.92 701.67 838.87 956.37 1,040.32 869.14 963.21 836.04 721.59 614.82 543.82 791.15 766.66 882.17
Asset Turnover
26.60 27.78 31.14 30.40 31.85 30.19 30.57 31.06 28.13 26.13 29.15 31.32 36.63 34.06 32.14
Coverage
Interest Coverage
607.96 677.82 392.73 724.09 205.07 408.89 469.82 253.26 308.78 396.15 453.22 760.12 1,156.61 910.70 833.64
Asset Coverage
200 300 400 300 300 200 300 300 200 200 200 200 200 200 300
Cash Flow Coverage (CFGR)
22.82 28.72 41.49 28.91 30.63 24.57 29.94 31.98 16.30 16.53 19.39 24.29 32.91 38.43 29.99
EBITDA Coverage
1,000 700 500 800 300 400 900 700 700 700 700 1,000 1,600 1,400 1,200
Dividend Coverage
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Time Interest Earned (TIE)
100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
Market Prospects
Dividend Yield
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Yield
2.98 3.16 2.97 3.04 1.24 2.14 1.97 1.22 0.57 2.45 -0.56 0.63 4.17 3.84 3.45
Price/Earnings (P/E)
3,357.06 3,160.85 3,372.46 3,290.91 8,070.28 4,672.26 5,073.50 8,183.28 17,706.59 4,080.68 -17,935.37 15,901.95 2,397.81 2,601.25 2,902.90
Price/Book (P/B)
201.86 184.20 127.10 156.99 205.37 205.66 251.90 252.38 281.48 294.83 293.11 471.61 396.93 317.57 260.20
Price/Sales (P/S)
457.99 419.47 276.88 339.74 428.15 405.23 503.41 491.76 504.57 517.28 487.09 626.10 545.87 514.06 504.13
Price/Cash Flow (P/CF)
2,131.35 1,819.11 1,323.17 1,740.41 2,152.63 1,892.40 2,031.06 1,926.13 2,494.05 2,161.02 2,247.32 2,378.81 1,923.50 1,539.12 2,156.40
End of QGEN's Analysis
CIK: 1015820 CUSIP: N72482123 ISIN: NL0015001WM6 LEI: - UEI: -
Secondary Listings